Skip to main content
Clinical Trials/NL-OMON44151
NL-OMON44151CompletedNot Applicable

Bariatric procedures and changes in gut hormones and gastric passage - BIP-study

Rijnstate Ziekenhuis0 sites15 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • - Age > 18 years
  • - Patient underwent a standard RYGB (S-RYGB), B-RYGB or EP-RYGB and is a mean responder (clinic mean Excess Weight Loss +/- 10% or mean Total Body Weight Loss +/- 5%).
  • - Patient is able to adhere to the study visit schedule and protocol requirements
  • - Patient is able to give informed consent and the consent must be obtained prior to any study procedures
  • - Patient had a follow-up period of at least one year after S-RYGB, B-RYGB or EP-RYGB without any complications

Exclusion Criteria

  • - Binge-eating or associated eating disorder
  • - Active drug or alcohol addiction
  • - Pregnancy and when giving breast feeding
  • - Gluten allergy
  • - Inability to stop medication that affects the motility of the upper gastrointestinal tract (anti-cholinergic drugs, prokinetics, theophylline, calcium blocking agents, opioids)
  • - Endocrine disease influencing gastric emptying (diabetes mellitus, hyper- or hypothyroidism)

Investigators

Sponsor
Rijnstate Ziekenhuis

Similar Trials